Conditions placed on Ranbaxy acquisition
Sun Pharmaceuticals Industries can complete its $4 billion purchase of Ranbaxy Laboratories if it sells Ranbaxy’s interests in generic minocycline tablets to Torrent Pharmaceuticals Ltd., according to the Federal Trade Commission....
Subscription required to view this article.
This content can only be accessed by FTCWatch subscribers. If you are an FTCWatch subscriber, please login to access this contentIf you do not currently subscribe to FTCWatch please contact us for subscription information:
Email: customerservices@mlex.com
FTCWatch is delivered in the following formats: via email alert and online at mlexwatch.com/ftcwatch